InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 52.55
-0.45 (-0.85%)
Sep 10, 2026, 11:15 AM HKT
InSilico Medicine Cayman TopCo Employees
InSilico Medicine Cayman TopCo had 333 employees as of June 30, 2026. The number of employees increased by 16 or 5.05% since the number was reported on December 31, 2025.
Employees
333
Change
16
Growth
5.05%
Revenue / Employee
3.18M HKD
Profits / Employee
-7.01M HKD
Market Cap
30.52B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 333 | 16 | 5.05% |
| Dec 31, 2025 | 317 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 3SBio | 6,068 |
| Shanghai Henlius Biotech | 4,082 |
| RemeGen | 3,145 |
| Shanghai Junshi Biosciences | 3,055 |
| Biocytogen Pharmaceuticals (Beijing) | 1,922 |
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,768 |
| InnoCare Pharma | 1,388 |
InSilico Medicine Cayman TopCo News
- 2 days ago - Insilico's Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too - WSJ
- 7 days ago - Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain - PRNewsWire
- 14 days ago - InSilico Medicine Cayman TopCo Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - InSilico Medicine Cayman TopCo Earnings release: Q2 2026 - Filings
- 14 days ago - InSilico Medicine Cayman TopCo Slides: Q2 2026 - Filings
- 26 days ago - Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform - PRNewsWire
- 4 weeks ago - Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks - PRNewsWire
- 4 weeks ago - Insilico Medicine Announces 2026 Interim Earnings Conference Call Dates - PRNewsWire